Jill Tseng

1.5k total citations
35 papers, 723 citations indexed

About

Jill Tseng is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Jill Tseng has authored 35 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Reproductive Medicine, 19 papers in Obstetrics and Gynecology and 6 papers in Surgery. Recurrent topics in Jill Tseng's work include Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Uterine Myomas and Treatments (7 papers). Jill Tseng is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (17 papers) and Uterine Myomas and Treatments (7 papers). Jill Tseng collaborates with scholars based in United States, Netherlands and Canada. Jill Tseng's co-authors include Nadeem R. Abu‐Rustum, Ginger J. Gardner, Douglas A. Levine, Oliver Zivanovic, Kara Long Roche, Amanda N. Fader, Mario M. Leitão, S. Dennis, Yukio Sonoda and Fanny Dao and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Surgical Oncology.

In The Last Decade

Jill Tseng

31 papers receiving 715 citations

Peers

Jill Tseng

SURGE

ONCOL

Taymaa May Canada

Ram Eitan Israel

Birgit Volgger Austria

Alessandro Lucidi Italy

Kevin Schuler United States

Rosanna Mancari Italy

Mario Valenzano Menada Italy

Enrico Breda Italy

Edwin Alvarez United States

Anna V. Hoekstra United States

Taymaa May Canada

Jill Tseng

662 ×1.7

457 ×1.7

317 ×1.4

SURGE

259 ×1.6

ONCOL

125 ×0.9

Citations per year, relative to Jill Tseng Jill Tseng (= 1×) peers Taymaa May

Countries citing papers authored by Jill Tseng

Since Specialization

Citations

This map shows the geographic impact of Jill Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Tseng more than expected).

Fields of papers citing papers by Jill Tseng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Tseng. The network helps show where Jill Tseng may publish in the future.

Co-authorship network of co-authors of Jill Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Tseng. A scholar is included among the top collaborators of Jill Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Tseng. Jill Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Hong‐Shiee, et al.. (2025). Recurrent cesarean scar pregnancy successfully managed by laparoscopy: Case report and current trend. Taiwanese Journal of Obstetrics and Gynecology. 64(4). 711–715.

Tanyi, János L., Leslie M. Randall, Setsuko K. Chambers, et al.. (2023). A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Obstetrical & Gynecological Survey. 78(6). 341–342.

Richardson, Debra J., Jill Tseng, Theresa L. Werner, et al.. (2022). 33 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. Gynecologic Oncology Reports. 44. S16–S17. 2 indexed citations

Aloisi, Alessia, Jill Tseng, Theresa Kuhn, et al.. (2020). Robotic Surgery in the Frail Elderly: Analysis of Perioperative Outcomes. Annals of Surgical Oncology. 27(10). 3772–3780. 15 indexed citations

Cybulska, Paulina, Arnaud Da Cruz Paula, Jill Tseng, et al.. (2019). Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Gynecologic Oncology. 154(3). 516–523. 65 indexed citations

Tseng, Jill, Renee A. Cowan, Anoushka M. Afonso, et al.. (2018). Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecologic Oncology. 151(2). 287–293. 22 indexed citations

Tseng, Jill, Renee A. Cowan, Qin Zhou, et al.. (2018). Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?. Gynecologic Oncology. 151(1). 24–31. 58 indexed citations

Tseng, Jill, Alessia Aloisi, Yukio Sonoda, et al.. (2018). Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival. Gynecologic Oncology. 150(1). 44–49. 25 indexed citations

Cowan, Renee A., Jill Tseng, Vijayashree Murthy, et al.. (2018). Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center. Gynecologic Oncology. 149(1). 43–48. 8 indexed citations

10.

Aloisi, Alessia, Jill Tseng, Nancy Nguyen, et al.. (2018). Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment. Gynecologic Oncology. 151(3). 395–400. 12 indexed citations

11.

Tseng, Jill, Maria Bisogna, Lien Hoang, et al.. (2017). miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas. Scientific Reports. 7(1). 3614–3614. 22 indexed citations

12.

Cowan, Renee A., Jill Tseng, Vijayashree Murthy, et al.. (2017). Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecologic Oncology. 147(2). 262–266. 38 indexed citations

13.

Chambers, Laura, Chad M. Michener, Kimberly Levinson, et al.. (2017). Compliance with research standards within gynecologic oncology fellowship: A Gynecologic Oncology Fellowship Research Network (GOFRN) study. Gynecologic Oncology. 146(3). 647–652. 3 indexed citations

14.

Tseng, Jill, R.S. Suidan, Oliver Zivanovic, et al.. (2016). Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes. Gynecologic Oncology. 142(2). 217–224. 41 indexed citations

15.

Dao, Fanny, Brooke A. Schlappe, Jill Tseng, et al.. (2016). Characteristics of 10-year survivors of high-grade serous ovarian carcinoma. Gynecologic Oncology. 141(2). 260–263. 78 indexed citations

16.

Jelinic, Petar, Brooke A. Schlappe, Niamh Conlon, et al.. (2015). Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type. Modern Pathology. 29(1). 60–66. 50 indexed citations

17.

Tseng, Jill, Kara Long Roche, Amelia Jernigan, et al.. (2015). Lifestyle and Weight Management Counseling in Uterine Cancer Survivors. International Journal of Gynecological Cancer. 25(7). 1285–1291. 18 indexed citations

18.

Tseng, Jill, et al.. (2014). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality. Annals of Surgical Oncology. 22(2). 655–661. 18 indexed citations

19.

Doll, Kemi M., Jill Tseng, Sheri Denslow, Amanda N. Fader, & Paola A. Gehrig. (2013). High-grade endometrial cancer: Revisiting the impact of tumor size and location on outcomes. Gynecologic Oncology. 132(1). 44–49. 43 indexed citations

20.

Tergas, Ana I., Jill Tseng, & Robert E. Bristow. (2012). Impact of race and ethnicity on treatment and survival of women with vulvar cancer in the United States. Gynecologic Oncology. 129(1). 154–158. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact